Interleukin Foundation

Analysis

Interleukin Foundation is a registered charity in United States, based in Denver, CO. It received its IRS tax-exemption ruling in August 2014, 12 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Interleukin Foundation reported income of $219k and spending of $277k, spending 126% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $195k to $219k (+12%), an average of +2.9% a year. The sharpest change came in the year to December 2020, when income rose by 179%. Over the whole period it spent 91% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Interleukin Foundation sits at the 42nd percentile: it is larger than about 42% of them. Against every charity in United States with reported income it ranks in the 56th percentile, and in the 52nd percentile within CO. Charities of a similar size with the same main cause include Central California Fellowship of Alcoholics Anonymous ($219k), Cherokee Regional Medical Center Foundation ($219k) and Tennessee Jail Chemical Addiction Program ($219k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. At year end it held assets of $362k against liabilities of $0, net assets of $362k.